周三,生物技术公司 Alector Inc. 盘前暴跌超58%,其针对阿尔茨海默症研发的药物未能延缓病情进展。该公司将停止此项目的继续研究,并裁员49%。
周三,生物技术公司 Alector Inc. 盘前暴跌超58%,其针对阿尔茨海默症研发的药物未能延缓病情进展。该公司将停止此项目的继续研究,并裁员49%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.